Skip to Main Content
Phase COVID-IV

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

  • Study HIC#:2000021561
  • Last Updated:06/11/2020

Brief Summary:

To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.

  • Age18 years and older
  • GenderFemale only
  • Start Date10/01/2017
  • End Date10/30/2020

Trial Purpose and Description

The goal of this project is to develop and test an HIV prevention decision aid for women in drug treatment settings. Major outcomes of interest are uptake of HIV pre-exposure prophylaxis (PrEP) and use of other HIV prevention services.

Eligibility Criteria

Inclusion Criteria:

  • Self- identification as female (i.e., cis- or trans- women), age ≥18, HIV negative status (confirmed with APT date from rapid testing procedures), and entering or receiving treatment at our partnering site, the APT Foundation, Inc. (a drug treatment center).

Exclusion Criteria:

  • Women on PrEP at baseline, unable or unwilling to provide informed consent, threatening to staff, pregnant, or experiencing symptoms of physiological withdrawal that interfere with ability to provide informed consent

Sub-Investigator

For more information about this study, contact:

Or contact the Help us Discover team on: